Search research articles
Contact Us
Filters
Showing results (51-60 of 269) with videos related to
Page
of 27
Sort By:
Haematologica
|
December 11, 2013
The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients
Inge C Gyssens, Winfried V Kern, David M Livermore, et al.
International Journal of Antimicrobial Agents
|
February 1, 2011
Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae
David M Livermore, Shazad Mushtaq, Tue Nguyen, et al.
Antimicrobial Agents and Chemotherapy
|
November 11, 2015
Interactions of OP0595, a Novel Triple-Action Diazabicyclooctane, with β-Lactams against OP0595-Resistant Enterobacteriaceae Mutants
David M Livermore, Marina Warner, Shazad Mushtaq, et al.
International Journal of Antimicrobial Agents
|
May 12, 2009
Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates
David M Livermore, Shazad Mushtaq, Yigong Ge, et al.
The Journal of Antimicrobial Chemotherapy
|
January 24, 2009
Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci
David M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy
|
May 21, 2010
Proposed disc zone breakpoints for doripenem for use with the BSAC disc susceptibility testing method
Russell Hope, Teresa Pllana, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2017
WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases
Shazad Mushtaq, Anna Vickers, Neil Woodford, et al.
The Journal of Antimicrobial Chemotherapy
|
November 22, 2013
Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria
David M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy
|
August 28, 2015
Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases
David M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Lancet. Infectious Diseases
|
March 5, 2011
Balkan NDM-1: escape or transplant?
David M Livermore, Timothy R Walsh, Mark Toleman, et al.
Page
of 27
Search research articles
Search
Showing results (51-60 of 269) with videos related to
Sort By:
Page
of 27
Haematologica
|
December 11, 2013
The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients
Inge C Gyssens, Winfried V Kern, David M Livermore, et al.
International Journal of Antimicrobial Agents
|
February 1, 2011
Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae
David M Livermore, Shazad Mushtaq, Tue Nguyen, et al.
Antimicrobial Agents and Chemotherapy
|
November 11, 2015
Interactions of OP0595, a Novel Triple-Action Diazabicyclooctane, with β-Lactams against OP0595-Resistant Enterobacteriaceae Mutants
David M Livermore, Marina Warner, Shazad Mushtaq, et al.
International Journal of Antimicrobial Agents
|
May 12, 2009
Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates
David M Livermore, Shazad Mushtaq, Yigong Ge, et al.
The Journal of Antimicrobial Chemotherapy
|
January 24, 2009
Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci
David M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy
|
May 21, 2010
Proposed disc zone breakpoints for doripenem for use with the BSAC disc susceptibility testing method
Russell Hope, Teresa Pllana, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2017
WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases
Shazad Mushtaq, Anna Vickers, Neil Woodford, et al.
The Journal of Antimicrobial Chemotherapy
|
November 22, 2013
Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria
David M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy
|
August 28, 2015
Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases
David M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Lancet. Infectious Diseases
|
March 5, 2011
Balkan NDM-1: escape or transplant?
David M Livermore, Timothy R Walsh, Mark Toleman, et al.
Page
of 27